ANP32B and acute myeloid leukemia: Subsequent experiments utilizing kasumi-1 cells yielded similar findings (Fig. 5, Additional file 1: Fig. S4), thereby confirming the inhibitory effect of ANP32B knockdown on the viability of AML cells in vivo.